|

Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery

RECRUITINGN/ASponsored by Charles University, Czech Republic
Actively Recruiting
PhaseN/A
SponsorCharles University, Czech Republic
Started2025-06-19
Est. completion2027-06-19
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07320495

Summary

The Medtrum TouchCare Nano system with the APGO algorithm is the only patch pump-based automated insulin delivery system available in the Czech Republic. However, until now, no prospective clinical study has evaluated its efficacy and safety under real-world conditions. The RENEW study is the first to address this topic.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* patients with T1D
* type 1 diabetes for ≥1 years
* ≥ 18 years old
* written informed consent prior to starting study related activity

Exclusion Criteria:

* severe noncompliance
* lactation, pregnancy, intending to become pregnant during study
* use of medication with effects on carbohydrate metabolism

Conditions2

DiabetesDiabetes Mellitus, Type 1

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.